PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Recruiting Observational Study
Health Knowledge, Attitudes, Practice
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 – 80
Sex
Any
Study type
Observational
Participants needed
620 (estimated)
Sponsor
M.D. Anderson Cancer Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Men and women 55 to 80 years of age. 2. Participants must speak English. 3. Current smoker or quit smoking within the past 15 years. Exclusion Criteria: 1\. History of lung cancer.
Contacts

Robert Volk, PHD

713-563-2509

BVolk@mdanderson.org

CONTACT